Pharma Contract Commercialization (CCO) Market Size, Share & Trends Analysis Report By services (Value, Evidence and Access, Medical Affairs, Policy, Marketing, Sales and Consulting, Others), business model and end user, Region And Segment Forecasts, 2025-2034
Global Pharma Contract Commercialization (CCO) Market Size is valued at USD 42.6 Billion in 2024 and is predicted to reach USD 69.7 Billion by the year 2034 at a 5.1% CAGR during the forecast period for 2025-2034. A contract commercial organization (CCO) gives pharmaceutical businesses commercial services in order to boost performance, reduce risk, and speed up the transmission of medical innovation to patients. The main drivers of the pharma ...
Report ID: 2068 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 177
Fermentation Enabled Alternative Protein Market Size, Share & Trends Analysis Report By Process (Precision, Biomass, and Traditional Fermentation), By product type (Dairy, Meat, Egg white, Others), Region, And Segment Forecasts, 2025-2034
Fermentation Enabled Alternative Protein Market Size is valued at 472.91 Mn in 2024 and is predicted to reach 1768.38 Mn by the year 2034 at an 14.2% CAGR during the forecast period for 2025-2034. The alternative protein industry can be divided into three main areas: plant-based alternative proteins, cell-based alternative proteins, and fermentation-based alternative proteins. Fermentation-enabled alternative protein ...
Report ID: 1928 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Peptide CDMO (Pharmaceutical) Market Size, Share & Trends Analysis Report By Scale of Operation (Preclinical / Clinical, Commercial), By Method Used, (Chemical Synthesis Method, Non-Chemical Synthesis Method), By Applications, By Synthesis Types, By Region, And By Segment Forecasts, 2025-2034
The Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Peptides are bioactive molecules that bind to specific cell surface receptors, such as G protein-coupled receptors (GPCRs) or ion channels, where they trigger intracellular effects. Peptides have characteristics like safety, high specificit...
Report ID: 1202 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 175
Viral and Non-Viral Vector Manufacturing Market Size, Share & Trends Analysis Report By Vector type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases), By Application, By Region, And By Segment Forecasts, 2025-2034
Global Viral and Non-Viral Vector Manufacturing Market Size is valued at USD 8.0 Billion in 2024 and is predicted to reach USD 56.8 Billion by the year 2034 at a 21.9% CAGR during the forecast period for 2025-2034. Viral vectors are genetically modified viruses utilised as carriers for introducing exogenous genetic material into cells through their viral genome. In contrast, nonviral vectors encompass a range of chemical vectors, including ino...
Report ID: 1263 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 170
Next-Generation Biomanufacturing Market Size, Share & Trends Analysis Report By Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Other Applications), By Products, By Workflow, By End-User, By Region, And By Segment Forecasts, 2025-2034
Next-Generation Biomanufacturing Market Size is valued at 24.9 Billion in 2024 and is predicted to reach 80.0 Billion by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Supportive regulatory frameworks and guidelines from agencies like the FDA and EMA encourage the adoption of next-generation biomanufacturing technologies. The ability to adapt fastly ...
Report ID: 1261 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Antisense Oligonucleotide Therapeutics Market Size, Share & Trends Analysis Report, Analysis Report By By ASO Generation (First-Generation, Second-Generation, Third-Generation, Next-Generation), By Phase of Development, By Route of Administration, By Type of Therapy, By Indications, and By Drug Type, By Region, Forecasts, 2025-2034
Global Antisense Oligonucleotide Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034. Antisense oligonucleotide is crucial in present medicine because it inhibits the expression of disease-causing genes by acting on messenger RNA before the protein is produced. This is attributed to rising antisense drug acceptability, ...
Report ID: 1245 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
U.S. and Europe Concierge Medicine Market Size, Share & Trends Analysis Report By Type (Independent Concierge Physician, Network-Affiliated Concierge Physician), By Specialty Areas, By Region, And Segment Forecasts, 2025-2034
Global U.S. and Europe Concierge Medicine Market Size is valued at USD 11.1 Billion in 2024 and is predicted to reach USD 33.0 Billion by the year 2034 at a 11.8% CAGR during the forecast period for 2025-2034. Concierge medicine is an emerging healthcare business approach that includes the development of a connection between a patient and a healthcare professional. As a result, patients must pay an annual/monthly retainer fee in exchange for d...
Report ID: 1225 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Acquired Orphan Blood Disease Market Size, Share & Trends Analysis Report, By Therapy, By Disease Indication, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region, And by Segment Forecasts, 2025-2034
Acquired Orphan Blood Disease Market Size is valued at USD 9.4 Billion in 2024 and is predicted to reach USD 26.1 Billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: A key trend in the market is the development of targeted therapies and personalized medicine approaches, which aim to provide more precise and efficient treatments for patients. The increasing...
Report ID: 1456 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
mRNA Extraction and Purification Market Size, Share & Trends Analysis Report By Product (Kits/Reagents, Instruments), By Application(Infectious Disease Vaccines, Other Vaccines, Therapeutics and Others), By End-User, By Region, And Segment Forecasts, 2025-2034
Global mRNA Extraction and Purification Market Size is valued at USD 1105.2 Million in 2024 and is predicted to reach USD 7561.2 Million by the year 2034 at a 21.6% CAGR during the forecast period for 2025-2034. Purification and isolation or extraction processes are mandatory for all types of medical research. mRNA Purification and extraction are performed by using different kinds of methods. Many specialized methods are av...
Report ID: 1285 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Patient Support Programs (PSP) Market Size, Share & Trends Analysis Report By Functionality (Communication, Health Tracking & Insights, Billing & Payments, Administrative, Patient Education, Others), By Therapeutic area (Health & Wellness, Chronic Disease Management, Others), By Application, By End-user, By Region, And By Segment Forecasts, 2025-2034
Global Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034 at a 17.1% CAGR during the forecast period for 2025-2034. The patient support programs (PSP) market is a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to improve treatment outcomes. PSPs are i...
Report ID: 2197 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
Pharmaceuticals